NeuroSense Therapeutics Ltd. Deferred Compensation Arrangement with Individual, Compensation Expense
NeuroSense Therapeutics Ltd. (NRSN) reported Deferred Compensation Arrangement with Individual, Compensation Expense of $376.00 thousand for the 12-month period ending 2023-12-31, per its 6-K filed 2024-06-17.
Discontinued › Expense Statement › Operating Expenses
us-gaap:DeferredCompensationArrangementWithIndividualCompensationExpense · last filed 2024-06-17
| Period end | Deferred Compensation Arrangement with Individual, Compensation Expense 12 month |
|---|---|
| 2023-12-31 | $376.00K 6-K · filed 2024-06-17 |